Details for New Drug Application (NDA): 086569
✉ Email this page to a colleague
NDA 086569 describes THEOCLEAR L.A.-260, which is a drug marketed by Schwarz Pharma and is included in one NDA. Additional details are available on the THEOCLEAR L.A.-260 profile page.
The generic ingredient in THEOCLEAR L.A.-260 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOCLEAR L.A.-260 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 086569
| Tradename: | THEOCLEAR L.A.-260 |
| Applicant: | Schwarz Pharma |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086569
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 130MG | ||||
| Approval Date: | May 27, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 260MG | ||||
| Approval Date: | May 27, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
